Roche involved in DNA sequencing

Publié le : 6 June 2014

 On Monday, 2 June, the Swiss pharmaceutical group, Roche, announced that it had just purchased the Californian Company, Genia, which specialises in DNA sequencing. The cost of this acquisition: 125 million dollars.

Created in 2009, Genia “is developing technology which should reduce the cost of DNA sequencing whilst improving its rapidity of execution and precision“. 

Share this article

BIOETHICS PRESS SYNTHESIS